The Latest in Pharmacy

How AI Is Revolutionizing Drug Repurposing for Faster, Broader Impact

October 8, 2024

Pharmacy

FDA’s Project Optimus aims to transform early cancer research

November 14, 2023

FDA approves dasatinib for kids with Ph+ ALL

January 3, 2019

EC approves split dosing regimen for daratumumab

January 3, 2019

FDA approves first treatment for BPDCN

December 26, 2018

FDA approves ravulizumab for PNH

December 25, 2018

FDA approves calaspargase pegol-mknl for ALL

December 24, 2018

CHMP recommends treosulfan for allo-HSCT conditioning

December 21, 2018

CHMP backs lusutrombopag for severe thrombocytopenia

December 21, 2018

Long-acting interferon recommended for PV

December 20, 2018

CHMP backs dasatinib for kids with newly diagnosed ALL

December 19, 2018

Health Canada approves new indication for daratumumab

December 18, 2018

CHMP recommends BV+AVD for Hodgkin lymphoma

December 18, 2018

Romiplostim now approved for children with ITP

December 15, 2018

Serious side effect of AML treatment going unnoticed, FDA warns

November 30, 2018